Page last updated: 2024-12-07
cor 32-24
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
COR 32-24: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 93499 |
| CHEMBL ID | 4741106 |
| MeSH ID | M0159656 |
Synonyms (21)
| Synonym |
|---|
| 5-[(4-phenylpiperazin-1-yl)methyl]-4,5-dihydro-1,3-oxazol-2-amine |
| cor-32-24 |
| cor-3224 |
| 2-amino-5-(4-phenyl-1-piperazinylmethyl)-2-oxazoline |
| cor 32-24 |
| 4,5-dihydro-5-(4-phenyl-1-piperazinylmethyl)-2-oxazolamine |
| 4,5-dihydro-5-(methyl(4-phenyl-1-piperazinyl))-2-oxazolamine |
| cor 3224 |
| 2-oxazolamine, 4,5-dihydro-5-((4-phenyl-1-piperazinyl)methyl)- |
| 5-(1-phenyl-4-piperazino)methyl-2-amino-oxazoline |
| 91595-86-7 |
| 2-oxazolamine, 4,5-dihydro-5-[(4-phenylpiperazin-1-yl)methyl]- |
| XSZLHACSCSAKOF-UHFFFAOYSA-N , |
| 5-[(4-phenyl-1-piperazinyl)methyl]-4,5-dihydro-1,3-oxazol-2-amine # |
| cor3224 |
| 5-[(4-phenylpiperazin-1-yl)methyl]-1,3-oxazolidin-2-imine |
| DTXSID00919643 |
| pipoxazole |
| CHEMBL4741106 |
| PD159865 |
| AKOS040749213 |
Research Excerpts
Pharmacokinetics
| Excerpt | Reference | Relevance |
|---|---|---|
| " This method allowed the determination of pharmacokinetic parameters in six beagle dogs after intravenous and oral administration of 14C-labeled 1 ([14C]1) in a crossover study." | ( High-performance liquid chromatography of a new 2-amino-2-oxazoline: application to pharmacokinetic studies in dogs. Damaj, MI; Jacquot, C; Lambrey, B; Trouvin, JH, 1990) | 0.28 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (7)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 6 (85.71) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 13.01
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (13.01) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||